148 related articles for article (PubMed ID: 36917124)
1. Omadacycline therapy for Mycobacterium abscessus species infections.
Ingram PR; Jones EE; Allen B; Murray RJ; Keehner TJ; Whitmore TJ
Intern Med J; 2023 Dec; 53(12):2257-2263. PubMed ID: 36917124
[TBL] [Abstract][Full Text] [Related]
2.
Zhang T; Du J; Dong L; Wang F; Zhao L; Jia J; Wang C; Cheng M; Yu X; Huang H
Microbiol Spectr; 2023 Feb; 11(1):e0323822. PubMed ID: 36475850
[TBL] [Abstract][Full Text] [Related]
3.
Kaushik A; Ammerman NC; Martins O; Parrish NM; Nuermberger EL
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962331
[TBL] [Abstract][Full Text] [Related]
4. Omadacycline as a promising new agent for the treatment of infections with Mycobacterium abscessus.
Bax HI; de Vogel CP; Mouton JW; de Steenwinkel JEM
J Antimicrob Chemother; 2019 Oct; 74(10):2930-2933. PubMed ID: 31236595
[TBL] [Abstract][Full Text] [Related]
5. Potency of Omadacycline against Mycobacteroides abscessus Clinical Isolates
Nicklas DA; Maggioncalda EC; Story-Roller E; Eichelman B; Tabor C; Serio AW; Keepers TR; Chitra S; Lamichhane G
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0170421. PubMed ID: 34662184
[TBL] [Abstract][Full Text] [Related]
6. Omadacycline in first-line combination therapy for pulmonary Mycobacterium abscessus infection: a case series.
Duah M; Beshay M
Int J Infect Dis; 2022 Sep; 122():953-956. PubMed ID: 35798234
[TBL] [Abstract][Full Text] [Related]
7.
Brown-Elliott BA; Wallace RJ
Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33288634
[TBL] [Abstract][Full Text] [Related]
8. Omadacycline pharmacokinetics/pharmacodynamics in the hollow fiber model and clinical validation of efficacy to treat pulmonary Mycobacterium abscessus disease.
Singh S; Wang JY; Heysell SK; McShane PJ; Wadle C; Shankar P; Huang HL; Pasipanodya J; Boorgula GD; Philley JV; Gumbo T; Srivastava S
Int J Antimicrob Agents; 2023 Jul; 62(1):106847. PubMed ID: 37187338
[TBL] [Abstract][Full Text] [Related]
9. Omadacycline for management of Mycobacterium abscessus infections: a review of its effectiveness, place in therapy, and considerations for use.
Rizzo AR; Moniri NH
BMC Infect Dis; 2022 Nov; 22(1):874. PubMed ID: 36419143
[TBL] [Abstract][Full Text] [Related]
10. Efficacies of three drug regimens containing omadacycline to treat Mycobacteroides abscessus disease.
Rimal B; Panthi CM; Xie Y; Belz DC; Ignatius EH; Lippincott CK; Deck DH; Serio AW; Lamichhane G
Tuberculosis (Edinb); 2024 May; 146():102482. PubMed ID: 38364332
[TBL] [Abstract][Full Text] [Related]
11.
Fujiwara K; Aono A; Asami T; Morimoto K; Kamada K; Morishige Y; Igarashi Y; Chikamatsu K; Murase Y; Yamada H; Takaki A; Mitarai S
Antimicrob Agents Chemother; 2023 Jun; 67(6):e0157922. PubMed ID: 37154742
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Omadacycline-Containing Regimen in a Mouse Model of Pulmonary Mycobacteroides abscessus Disease.
Rimal B; Nicklas DA; Panthi CM; Lippincott CK; Belz DC; Ignatius EH; Deck DH; Serio AW; Lamichhane G
mSphere; 2023 Apr; 8(2):e0066522. PubMed ID: 36912629
[TBL] [Abstract][Full Text] [Related]
13. Omadacycline drug susceptibility testing for non-tuberculous mycobacteria using oxyrase to overcome challenges with drug degradation.
Boorgula GD; Gumbo T; Singh S; McShane PJ; Philley JV; Srivastava S
Tuberculosis (Edinb); 2024 Jul; 147():102519. PubMed ID: 38754247
[TBL] [Abstract][Full Text] [Related]
14.
Shoen C; Benaroch D; Sklaney M; Cynamon M
Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30858221
[TBL] [Abstract][Full Text] [Related]
15. Omadacycline for the Treatment of
Pearson JC; Dionne B; Richterman A; Vidal SJ; Weiss Z; Velásquez GE; Marty FM; Sax PE; Yawetz S
Open Forum Infect Dis; 2020 Oct; 7(10):ofaa415. PubMed ID: 33094118
[TBL] [Abstract][Full Text] [Related]
16. Omadacycline, Eravacycline, and Tigecycline Express Anti-Mycobacterium abscessus Activity
Li A; He S; Li J; Zhang Z; Li B; Chu H
Microbiol Spectr; 2023 Jun; 11(3):e0071823. PubMed ID: 37140428
[TBL] [Abstract][Full Text] [Related]
17. Omadacycline in the Treatment of Mycobacterium abscessus Infection.
Madariaga MG
Clin Infect Dis; 2020 Aug; 71(4):1124. PubMed ID: 31612905
[No Abstract] [Full Text] [Related]
18. Long-term Safety and Tolerability of Omadacycline for the Treatment of
Mingora CM; Bullington W; Faasuamalie PE; Levin A; Porter G; Stadnick R; Varley CD; Addrizzo-Harris D; Daley CL; Olivier KN; Winthrop KL; Dorman SE; Flume PA
Open Forum Infect Dis; 2023 Jul; 10(7):ofad335. PubMed ID: 37476076
[TBL] [Abstract][Full Text] [Related]
19. Minimum Inhibitory Concentrations before and after Antibacterial Treatment in Patients with Mycobacterium abscessus Pulmonary Disease.
Fujiwara K; Uesugi F; Furuuchi K; Tanaka Y; Yoshiyama T; Saotome M; Ohta K; Mitarai S; Morimoto K
Microbiol Spectr; 2021 Dec; 9(3):e0192821. PubMed ID: 34878300
[TBL] [Abstract][Full Text] [Related]
20.
Brown-Elliott BA; Wallace RJ
Antimicrob Agents Chemother; 2022 Sep; 66(9):e0068922. PubMed ID: 35943269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
